EU approves Cenrifki for secondary progressive multiple sclerosis without relapses

Japan approves Wayrilz for immune thrombocytopenia treatment

Nura Bio completes USD73.8m Series B financing, advances clinical-stage SARM1 inhibitor programmes

Oxford BioTherapeutics reports progress in Boehringer Ingelheim partnered programmes

Sanofi appoints new global head of Research & Development Pharma

Genprex receives Canadian Patent Allowance for Reqorsa gene therapy combination in lung cancer

Transgene expands myvac platform into non-small cell lung cancer with TG4070

BioArctic and Eli Lilly enter BrainTransporter collaboration with up to USD800m in milestone payments

Fusion Antibodies secures Canadian patent allowance for antibody library technology

Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB

Sanofi's Sarclisa SC formulation gains Japanese approval to treat multiple myeloma

Arletta Pharma Solutions names new chief medical officer

Kither Biotech completes Phase 1 KIT2014 clinical study

Novo Nordisk Foundation funds European initiative to accelerate drug discovery for cardiometabolic diseases

Solvonis reports positive bridging data for SVN-002 ahead of planned US Phase 2b